Vanguard Group Inc Protara Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,801,980 shares of TARA stock, worth $5.53 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,801,980
Previous 1,602,852
12.42%
Holding current value
$5.53 Million
Previous $6.83 Million
20.05%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TARA
# of Institutions
81Shares Held
27.7MCall Options Held
37.2KPut Options Held
65.1K-
Janus Henderson Group PLC London, X04.1MShares$12.6 Million0.01% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA2.14MShares$6.57 Million11.14% of portfolio
-
Blackstone Inc New York, NY1.91MShares$5.86 Million0.03% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.75MShares$5.38 Million3.47% of portfolio
-
Catalio Capital Management, LP New York, NY1.63MShares$4.99 Million1.03% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $34.6M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...